Why the study?
Do the DNS and DNE scores accurately diagnose diabetic polyneuropathy and correlate with cardiovascular autonomic function testing and electro-diagnostic studies in diabetic patients?
Do the DNS and DNE scores accurately diagnose diabetic polyneuropathy and correlate with cardiovascular autonomic function testing and electro-diagnostic studies in diabetic patients?
The DNS and DNE scores are valid clinical tools for diagnosing diabetic polyneuropathy, correlating well with objective autonomic and electro-diagnostic testing.
Answers are grounded in this paper and cite their sources.
May aid neuropathy screening in diabetes care; supports validity via objective correlations yet leaves open prospective validation.
OBJECTIVE: To evaluate the discriminative power of the Diabetic Neuropathy Symptom (DNS) and Diabetic Neuropathy Examination (DNE) scores for diagnosing diabetic polyneuropathy (PNP), as well as their relation with cardiovascular autonomic function testing (cAFT) and electro-diagnostic studies (EDS). RESEARCH DESIGN AND METHODS: Three groups (matched for age and sex) were selected: 24 diabetic patients with neuropathic foot ulcers (DU), 24 diabetic patients without clinical neuropathy or ulcers (DC), and 21 control subjects without diabetes (C). In all participants, the DNS and DNE scores were assessed and cAFT (heart rate variability [HRV], baroreflex sensitivity [BRS]), and EDS were performed (Nerve Conduction Sum [NCS] score; muscle fiber conduction velocity: fastest/slowest ratio [F/S ratio]). RESULTS: Both the DNS and the DNE scores discriminated between the DU and DC groups significantly (P < 0.001). The DNE score even discriminated between DC and C (P < 0.05). Spearman's correlation coefficients between both DNS and DNE scores and cAFT (HRV -0.42 and -0.44; BRS -0.30 and -0.29, respectively) and EDS (NCS 0.51 and 0.62; F/S ratio 0.44 and 0.62, respectively) were high. Odds ratios were calculated for both DNS and DNE scores with cAFT (HRV 4.4 and 5.7; BRS 20.7 and 14.2, respectively) and EDS (NCS 5.6 and 16.8; F/S ratio 7.2 and 18.8, respectively). CONCLUSIONS: The DNS and DNE scores are able to discriminate between patients with and without PNP and are strongly related to cAFT and EDS. This further confirms the strength of the DNS and DNE scores in diagnosing diabetic PNP in daily clinical practice.
No takes yet. Share an insight, caveat, or question.
Meijer et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: